Table 3.
Bacterial taxa showing significant difference in relative abundances in ileal MAM between healthy control and patients with Crohn’s disease.
| Taxa | Healthy control (n = 23) |
Patients with Crohn's disease (n = 32) |
P-value † |
|---|---|---|---|
| g__Faecalibacterium * | 7.94 ± 6.41 | 3.13 ± 4.93 | 0.004 |
| f__Lachnospiraceae (unclassified genus) | 7.39 ± 7.58 | 3.11 ± 3.42 | 0.017 |
| g__Blautia * | 5.66 ± 3.79 | 3.22 ± 3.38 | 0.018 |
| g__Ruminococcus * | 3.19 ± 3.10 | 1.03 ± 1.84 | 0.005 |
| g__Coprococcus * | 2.51 ± 1.99 | 0.93 ± 2.06 | 0.006 |
| g__Roseburia * | 2.48 ± 2.11 | 0.77 ± 1.62 | 0.002 |
| g__Gemmiger * | 2.15 ± 2.34 | 0.57 ± 1.57 | 0.008 |
| g__Butyricicoccus * | 0.63 ± 0.64 | 0.25 ± 0.49 | 0.021 |
| g__Sutterella | 0.57 ± 0.50 | 1.17 ± 1.47 | 0.038 |
| g__Clostridium (Lachnospiraceae) | 0.33 ± 0.36 | 1.23 ± 2.11 | 0.023 |
Values mean relative abundance (% of total bacteria) and are shown as mean ± standard deviation.
Bold font shows statistically higher values among the two groups compared.
* Genus including butyrate-producing species or isolate
† P-values were calculated using Welch’s t-test
MAM, mucosa-associated microbiota